New, once-a-day eyedrops that control glaucoma have been licensed by the U.S. Food and Drug Administration. The eyedrops, which are called Betagan, worked well in 72 percent of patients who used them during test studies and have fewer side effects than currently used twice-a-day glaucoma drops.
The new drug was developed by Allergan Pharmaceuticals of Irvine, Calif., and can be obtained only by a doctor`s prescription.
Originally Published:
